| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000043078 |
| Receipt No. | R000049181 |
| Scientific Title | Impact of serum magnesium and bone mineral density on systemic fractures in chronic hemodialysis patients |
| Date of disclosure of the study information | 2021/01/21 |
| Last modified on | 2021/01/21 (Ver. 1) |
| Basic information | ||
| Public title | Impact of serum magnesium and bone mineral density on systemic fractures in chronic hemodialysis patients | |
| Acronym | Mg and BMD on fractures among HD patients | |
| Scientific Title | Impact of serum magnesium and bone mineral density on systemic fractures in chronic hemodialysis patients | |
| Scientific Title:Acronym | Mg and BMD on fractures among HD patients | |
| Region |
|
|
| Condition | |||
| Condition | End-stage renal failure
fragility fractures |
||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To assess the association of serum magnesium and BMD with the risk of incident fractures in patients undergoing hemodialysis |
| Basic objectives2 | Others |
| Basic objectives -Others | Investigation for the marker which improved the prediction of fractures |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Any type of fragility fractures |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | patients who had undergone hemodialysis for least 2 months at Masuko Memorial Hospital | |||
| Key exclusion criteria | Patients undergoing combination therapy with peritoneal dialysis were excluded. | |||
| Target sample size | 350 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Masuko Memorial Hospital | ||||||
| Division name | Nephrology | ||||||
| Zip code | 453-8566 | ||||||
| Address | Nakamura-ku Nagoya | ||||||
| TEL | +81524511307 | ||||||
| m-hori@masuko.or.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Masuko Memorial Hospital | ||||||
| Division name | Nephrology | ||||||
| Zip code | 453-8566 | ||||||
| Address | Nakamura-ku Nagoya | ||||||
| TEL | +81524511307 | ||||||
| Homepage URL | |||||||
| m-hori@masuko.or.jp | |||||||
| Sponsor | |
| Institute | Masuko Memorial Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Masuko Memorial Hospital |
| Address | 35-28 Takehashi-cho, |
| Tel | +81524511307 |
| m-hori@masuko.or.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 増子記念病院(愛知県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | 358 |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | assess the association of serum magnesium and BMD with the risk of incident fractures and to determine whether the prediction of the risk of fractures in patients undergoing hemodialysis based on the combination of Mg level and lumbar spine BMD is more accurate than the prediction based on either variable alone |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049181 |